Diabetes Mellitus, Type 2
Conditions
Keywords
artificial intelligence, diabetes mellitus, self-care, telemedicine
Brief summary
Using a smart device (Beprevent) to monitor activities of daily living improves the lifestyle of patients with DM2
Detailed description
A 6-month randomized clinical trial to evaluate a home activity control system (Beprevent) in the management of the patient with DM2, through the individualized labeling of objects related to them. The study will include 20 patients with DM2 (10 in the intervention group and 10 in the control group) who live alone or with people who can´t move on their own. Data will be recorded to measure the degree of satisfaction of professionals and participants in the study, and clinical and epidemiological data at the start of the study (in its baseline situation) and at the end of the study (at 6 months), to assess the changes produced and Compare them between both study groups.
Interventions
OTHERBeprevent
10 will become part of the intervention group. At first, they are given a series of questionnaires, later (1 day later) we stay at their home to install the Beprevent device, which will remain in their home for a period of two weeks, to finish and once the device of your home, we will proceed to pass the same questionnaires as at the beginning of the test, in order to compare results.
Sponsors
Universidad Católica San Antonio de Murcia
Maimónides Biomedical Research Institute of Córdoba
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ≥ 18 years, with the ability to give informed consent * Patient who has autonomy to carry out activities of daily living (Barthel = 100) * patient diagnosed with Diabetes Mellitus * patient in pharmacological treatment * To live alone or with a person who cannot move on their own * they do not plan to change their address in the 6 months after inclusion in the study
Exclusion criteria
• DM2 patients whose most recent HbA1c value is ≤7%
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diabetes Knowledge Questionnaire | 15 minuts | The Diabetes Knowledge Questionnaire (DKQ-24) is a questionnaire made up of 24 questions about basic knowledge of the disease (10 items), glycemic control (7 items) and prevention of complications (7 items). The questions are closed, with answer options yes, no and I don't know. Its maximum score is 24. The patient has better knowledge about diabetes the higher the score. |
Contacts
Primary ContactAntonio Luque
Backup ContactPEDRO MONTAGUT MARTINEZ, nurse
Outcome results
None listed